News Image

Don't overlook NASDAQ:LNTH—it's a hidden gem with strong fundamentals and an attractive price tag.

By Mill Chart

Last update: Oct 19, 2023

Our stock screening tool has identified LANTHEUS HOLDINGS INC (NASDAQ:LNTH) as an undervalued gem with strong fundamentals. NASDAQ:LNTH boasts decent financial health and profitability while maintaining an attractive price point. We'll break it down further.

Valuation Assessment of NASDAQ:LNTH

ChartMill assigns a Valuation Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing different valuation elements, such as price to earnings and free cash flow, both in absolute terms and relative to the market and industry. In the case of NASDAQ:LNTH, the assigned 8 reflects its valuation:

  • 94.53% of the companies in the same industry are more expensive than LNTH, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.55, LNTH is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 11.30, the valuation of LNTH can be described as reasonable.
  • LNTH's Price/Forward Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 94.53% of the companies in the same industry.
  • LNTH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 18.74.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LNTH indicates a somewhat cheap valuation: LNTH is cheaper than 75.62% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 94.03% of the companies listed in the same industry.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LNTH has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as LNTH's earnings are expected to grow with 18.78% in the coming years.

Assessing Profitability for NASDAQ:LNTH

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:LNTH scores a 6 out of 10:

  • LNTH's Return On Assets of 2.49% is fine compared to the rest of the industry. LNTH outperforms 78.61% of its industry peers.
  • With an excellent Return On Equity value of 6.04%, LNTH belongs to the best of the industry, outperforming 81.09% of the companies in the same industry.
  • LNTH has a Return On Invested Capital of 10.74%. This is amongst the best in the industry. LNTH outperforms 92.54% of its industry peers.
  • LNTH has a better Profit Margin (2.97%) than 75.62% of its industry peers.
  • The Operating Margin of LNTH (14.30%) is better than 86.57% of its industry peers.
  • The Gross Margin of LNTH (63.18%) is better than 67.16% of its industry peers.
  • In the last couple of years the Gross Margin of LNTH has grown nicely.

Evaluating Health: NASDAQ:LNTH

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:LNTH, the assigned 7 reflects its health status:

  • An Altman-Z score of 5.35 indicates that LNTH is not in any danger for bankruptcy at the moment.
  • LNTH has a better Altman-Z score (5.35) than 82.09% of its industry peers.
  • The Debt to FCF ratio of LNTH is 2.29, which is a good value as it means it would take LNTH, 2.29 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LNTH (2.29) is better than 92.54% of its industry peers.
  • Although LNTH does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
  • LNTH has a Current Ratio of 4.88. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
  • LNTH has a better Current ratio (4.88) than 62.69% of its industry peers.
  • LNTH has a Quick Ratio of 4.55. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
  • LNTH has a better Quick ratio (4.55) than 66.67% of its industry peers.

Understanding NASDAQ:LNTH's Growth Score

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NASDAQ:LNTH has earned a 8 for growth:

  • LNTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 145.21%, which is quite impressive.
  • Measured over the past years, LNTH shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.91% on average per year.
  • LNTH shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.36%.
  • Measured over the past years, LNTH shows a very strong growth in Revenue. The Revenue has been growing by 23.05% on average per year.
  • Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.39% on average per year.
  • LNTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.49% yearly.

More Decent Value stocks can be found in our Decent Value screener.

Our latest full fundamental report of LNTH contains the most current fundamental analsysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (4/19/2024, 7:01:46 PM)

After market: 63.81 0 (0%)

63.81

+1.48 (+2.37%)

LNTH News

News Image3 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
News Image3 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image4 days ago - ChartmillNASDAQ:LNTH: a strong growth stock preparing for the next leg up?.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.

News Image9 days ago - The Motley Fool2 Magnificent Stocks You Probably Never Heard Of

You might not have heard of these stocks, but they're worth putting on your radar.

News Image10 days ago - ChartmillInvestors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued stock with good fundamentals.

News Image11 days ago - InvestorPlaceWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024

Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations.

News Image19 days ago - Market News VideoInteresting LNTH Put And Call Options For May 17th
News Image19 days ago - ChartmillNASDAQ:LNTH is showing good growth, while it is not too expensive.

Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image2 months ago - Lantheus Holdings, Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms

LNTH Links
Follow us for more